Akebia Therapeutics Inc (AKBA)
1.36
-0.01
(-0.73%)
USD |
NASDAQ |
Apr 23, 16:00
1.36
0.00 (0.00%)
After-Hours: 17:02
Akebia Therapeutics Net Income (TTM): -51.26M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -51.26M |
| September 30, 2023 | -57.95M |
| June 30, 2023 | -97.56M |
| March 31, 2023 | -56.94M |
| December 31, 2022 | -93.14M |
| September 30, 2022 | -156.93M |
| June 30, 2022 | -162.38M |
| March 31, 2022 | -274.86M |
| December 31, 2021 | -282.02M |
| September 30, 2021 | -300.55M |
| June 30, 2021 | -300.96M |
| March 31, 2021 | -393.67M |
| December 31, 2020 | -384.84M |
| September 30, 2020 | -390.94M |
| June 30, 2020 | -385.57M |
| March 31, 2020 | -267.98M |
| December 31, 2019 | -279.66M |
| September 30, 2019 | -245.23M |
| June 30, 2019 | -216.69M |
| March 31, 2019 | -192.59M |
| December 31, 2018 | -143.59M |
| Date | Value |
|---|---|
| September 30, 2018 | -68.01M |
| June 30, 2018 | -65.10M |
| March 31, 2018 | -52.55M |
| December 31, 2017 | -73.67M |
| September 30, 2017 | -127.06M |
| June 30, 2017 | -140.23M |
| March 31, 2017 | -154.49M |
| December 31, 2016 | -135.75M |
| September 30, 2016 | -117.74M |
| June 30, 2016 | -100.91M |
| March 31, 2016 | -75.82M |
| December 31, 2015 | -60.72M |
| September 30, 2015 | -51.23M |
| June 30, 2015 | -41.10M |
| March 31, 2015 | -38.03M |
| December 31, 2014 | -37.03M |
| September 30, 2014 | -32.61M |
| June 30, 2014 | -27.03M |
| March 31, 2014 | -22.24M |
| December 31, 2013 | -13.17M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-393.67M
Minimum
Mar 2021
-51.26M
Maximum
Dec 2023
-231.53M
Average
-267.98M
Median
Mar 2020
Net Income (TTM) Benchmarks
| Ocugen Inc | -63.08M |
| Aquestive Therapeutics Inc | -7.87M |
| SELLAS Life Sciences Group Inc | -37.34M |
| Protagonist Therapeutics Inc | -78.96M |
| Stoke Therapeutics Inc | -104.70M |